Australia markets closed

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
13.820-0.040 (-0.29%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-379,459
-379,459
-402,894
-732,949
Depreciation & amortisation
22,583
22,583
17,617
13,176
Stock-based compensation
71,642
71,642
103,829
34,017
Change in working capital
-75,317
-75,317
22,052
-24,077
Other working capital
-370,245
-370,245
-261,934
-315,794
Other non-cash items
-5,146
-5,146
-8,718
965
Net cash provided by operating activities
-367,554
-367,554
-238,710
-190,541
Cash flows from investing activities
Investments in property, plant and equipment
-2,691
-2,691
-23,224
-125,253
Purchases of investments
-525,368
-525,368
0
-329,000
Sales/maturities of investments
222,399
222,399
0
352,652
Other investing activities
-
-
8,126
-9,273
Net cash used for investing activities
-294,845
-294,845
49
-108,722
Net change in cash
-331,364
-331,364
-59,281
493,770
Cash at beginning of period
635,212
635,212
668,326
183,674
Cash at end of period
306,983
306,983
635,212
668,326
Free cash flow
Operating cash flow
-367,554
-367,554
-238,710
-190,541
Capital expenditure
-2,691
-2,691
-23,224
-125,253
Free cash flow
-370,245
-370,245
-261,934
-315,794